
OM
Outset Medical Inc.
$13.91
-$0.01(-0.07%)
51
Overall
--
Value
50
Tech
52
Quality
Market Cap
$250.50M
Volume
541.29K
52W Range
$5.85 - $25.35
Target Price
$25.75
Order:
Income Statement
Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|
REVENUE | |||||||
Total Revenue | $49.9M | $102.6M | $115.4M | $130.4M | $113.7M | ||
Total Revenue | $49.9M | $102.6M | $115.4M | $130.4M | $113.7M | ||
COST OF GOODS SOLD | |||||||
Cost of Revenue | $63.0M | $95.0M | $97.5M | $101.4M | $75.1M | ||
GROSS PROFIT | |||||||
Gross Profit | $-13.0M | $7.6M | $17.8M | $29.0M | $38.6M | ||
OPERATING EXPENSES | |||||||
Operating Expenses | $104.4M | $138.1M | $178.9M | $198.8M | $151.9M | ||
Research & Development | $28.9M | $36.7M | $48.9M | $57.3M | $38.4M | ||
Research Expense | $28.9M | $36.7M | $48.9M | $57.3M | $38.4M | ||
Selling, General & Administrative | $75.6M | $101.4M | $130.0M | $141.5M | $113.5M | ||
Selling & Marketing Expenses | $45.1M | $65.1M | $89.5M | $96.2M | $70.0M | ||
General & Administrative Expenses | $30.5M | $36.3M | $40.5M | $45.2M | $43.5M | ||
Salaries & Wages | -- | -- | $27.2M | $38.6M | $29.4M | ||
Depreciation & Amortization | $3.2M | $5.2M | $5.2M | $5.8M | $5.7M | ||
Depreciation & Amortization | $3.2M | $5.2M | $5.2M | $5.8M | $5.7M | ||
Amortization | $6.0K | -- | -- | -- | -- | ||
Other Operating Expenses | $-562.0K | $-608.0K | $-800.0K | $-754.0K | $-642.0K | ||
OPERATING INCOME | |||||||
Operating income | $-117.5M | $-130.5M | $-161.0M | $-169.8M | $-113.4M | ||
EBITDA | $-115.4M | $-124.9M | $-153.9M | $-153.8M | $-97.9M | ||
NON-OPERATING ITEMS | |||||||
Interest Expense (Non-Operating) | $2.9M | $1.7M | $3.6M | $12.7M | $23.9M | ||
Net Non-Operating Interest Income/Expense | $-2.9M | $-1.7M | $275.0K | $-12.7M | $-23.9M | ||
Other Income/Expense | $1.0M | $-498.0K | $-1.4M | $-10.2M | $-9.8M | ||
Other Special Charges | $-1.0M | $498.0K | $1.9M | $10.2M | $9.8M | ||
SPECIAL ITEMS | |||||||
Restructring And Mn A Income | -- | -- | -- | $2.5M | $5.6M | ||
Special Income Charges | -- | -- | -- | $-2.5M | $-5.6M | ||
PRE-TAX INCOME | |||||||
EBIT | $-118.6M | $-130.0M | $-159.1M | $-159.6M | $-103.6M | ||
Pre-Tax Income | $-121.5M | $-131.7M | $-162.7M | $-172.3M | $-127.5M | ||
INCOME TAX | |||||||
Tax Provision | -- | $199.0K | $295.0K | $523.0K | $491.0K | ||
NET INCOME | |||||||
Net Income | $-121.5M | $-131.9M | $-163.0M | $-172.8M | $-128.0M | ||
Net Income (Continuing Operations) | $-121.5M | $-131.9M | $-163.0M | $-172.8M | $-128.0M | ||
Net Income (Discontinued Operations) | $-121.5M | $-131.9M | $-163.0M | $-172.8M | $-128.0M | ||
Net Income (Common Stockholders) | $-121.4M | $-131.9M | $-163.0M | $-172.8M | $-128.0M | ||
Normalized Income | -- | -- | -- | -- | $-123.0M | ||
TOTALS | |||||||
Total Expenses | $167.4M | $233.1M | $276.4M | $300.1M | $227.1M | ||
SHARE & EPS DATA | |||||||
Average Shares Outstanding | $1.1M | $3.0M | $3.2K | $3.3K | $52.0K | ||
Average Shares Outstanding (Diluted) | $1.1M | -- | $3.2K | $3.3K | $52.0K | ||
Shares Outstanding | $2.9M | $3.2M | $3.2M | $3.4M | $53.9M | ||
Basic EPS | $-72.75 | $-43.35 | $-50.7 | $-52.2 | $-2.46 | ||
Basic EPS (Continuing Operations) | $-72.75 | $-43.35 | $-50.7 | $-52.2 | $-2.46 | ||
Diluted EPS | $-72.75 | $-43.35 | $-50.7 | $-52.2 | $-2.46 | ||
Diluted EPS (Continuing Operations) | -- | -- | $-50.7 | $-52.2 | $-2.46 | ||
OTHER METRICS | |||||||
Accretion On Preferred Stock | $362.0K | -- | -- | -- | -- | ||
Other Gand A | $30.5M | $36.3M | $40.5M | $45.2M | $43.5M | ||
Other Write Off | -- | -- | -- | -- | $-2.4M | ||
Otherunder Preferred Stock Dividend | $362.0K | -- | -- | -- | -- | ||
Preferred Stock Dividends | $362.0K | -- | -- | -- | -- | ||
Restruct | -- | -- | -- | $2.5M | $5.6M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | OM | $13.91 | -0.1% | 541.29K |
3 | ||||
4 | ||||
5 | ||||
6 |